Skip to content

: Effect of adding adjuvant dexmedetomidine to local anaesthesia for vitreoretinal surgery

: Effect of adding dexmedetomidine to 0.75% ropivacaine in peribulbar block for vitreoretinal surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/07/020225
Enrollment
100
Registered
2019-07-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H338- Other retinal detachments Health Condition 2: H330- Retinal detachment with retinal break Health Condition 3: H356- Retinal hemorrhage Health Condition 4: H334- Traction detachment of retina

Interventions

Intervention1: 0.75% ropivacaine, hyaluronidase, normal saline: Group R (8 ml of 0.75% Ropivacaine + 0.5 ml normal saline + hyaluronidase 37.5u/ml) Control Intervention1: 0.75% ropivacaine, hyaluronid

Sponsors

Narayana Nethralaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 100 ASA I-III adult patients aged greater than 18 years, undergoing vitreoretinal surgery under peribulbar block will be included in the study after obtaining a written informed consent. All patients will undergo routine pre-operative evaluation for vitreoretinal surgery.

Exclusion criteria

Exclusion criteria: Patients with history of hypersensitivity to the study drugs, significant cardiovascular disease (second [Mobitz II type] or third degree heart block, obstructive sleep apnea, chronic clonidine therapy, coagulopathy, impaired mental status, refusal to use local anaesthestic technique and pregnancy will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
The primary outcome is the requirement of supplementation of peribulbar block prior to or during the surgery.Timepoint: 0,1,2,3,4,5,10, 15 min and every 15 min till end of surgery

Secondary

MeasureTime frame
2. The secondary outcome is the post-operative analgesic requirement.Timepoint: 1h,2h,6h,24h post op

Countries

India

Contacts

Public ContactShalini Subramanian

Narayana nethralaya

drshalinisubramanian@gmail.com7406610222

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026